XML 34 R7.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Statement of Cash Flows - USD ($)
 1 Months Ended 3 Months Ended 10 Months Ended 12 Months Ended
Mar. 31, 2021
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Dec. 31, 2021
Dec. 31, 2020
Cash Flows from Operating Activities:            
Net loss   $ (67,486,000) $ (11,609,000)   $ (55,146,000) $ (26,749,000)
Adjustments to reconcile net loss to net cash used in operating activities:            
Depreciation and amortization   710,000 361,000   1,984,000 964,000
Equity-based compensation expense   52,684,000 175,000   699,000 730,000
Changes in operating assets and liabilities:            
Other assets   (3,843,000) 249,000   (5,704,000) (809,000)
Accounts payable and accrued expenses   1,519,000 3,568,000   7,868,000 683,000
Income taxes payable   957,000        
Net cash used in operating activities   (15,459,000) (7,256,000)   (50,299,000) (25,181,000)
Cash Flows from Investing Activities:            
Proceeds from sale of equipment         1,000 0
Purchase of equipment and facility expansion   (839,000) (1,389,000)   (5,192,000) (5,456,000)
Net cash used in investing activities   (839,000) (1,389,000)   (5,191,000) (5,456,000)
Cash Flows from Financing Activities            
Payments on finance leases   (8,000) (7,000)   (30,000) (11,000)
Borrowings under related party notes payable   20,000,000        
Net cash contribution   5,550,000 20,000,000   71,500,000 20,000,000
Net cash flows from financing activities   25,542,000 19,993,000   71,470,000 19,989,000
Net change in cash and cash equivalents   9,244,000 11,348,000   15,980,000 (10,648,000)
Cash, beginning of period   20,558,000 4,577,000   4,577,000  
Cash, beginning of period   20,558,000 4,578,000   4,578,000 15,226,000
Cash, end of period $ 15,925,000 29,802,000 15,925,000 $ 20,558,000 20,558,000 4,577,000
Cash, end of period       20,558,000 20,558,000 4,578,000
Supplemental disclosure of non-cash investing activities:            
Right of use assets obtained in exchange for lease obligations   496,000        
Equipment and facility expansion included in accounts payable and accrued expenses   501,000 $ 910,000   1,295,000 $ 1,840,000
Social Capital Suvretta Holdings Corp. III [Member]            
Cash Flows from Operating Activities:            
Net loss (5,182) (3,981,025)   (2,324,629)    
Adjustments to reconcile net loss to net cash used in operating activities:            
Formation costs paid by Sponsor in exchange for issuance of Founder Shares 5,000     5,000    
Interest earned on marketable securities held in Trust Account 0 (25,176)   (8,324)    
Changes in operating assets and liabilities:            
Prepaid expenses   84,851   (751,689)    
Accounts payable       5,000    
Accrued expenses       1,864,796    
Advances from related party   33,623        
Accounts payable and accrued expenses 44 3,499,128        
Net cash used in operating activities (138) (388,599)   (1,209,846)    
Cash Flows from Investing Activities:            
Investment of cash into Trust Account       (250,000,000)    
Net cash used in investing activities       (250,000,000)    
Cash Flows from Financing Activities            
Proceeds from sale of Public Shares, net of underwriting discounts paid       245,600,000    
Proceeds from sale of Private Placement Shares       6,400,000    
Advances from related party       97,319    
Repayment of advances from related party       (87,319)    
Proceeds from promissory note—related party 255     300,000    
Repayment of promissory note—related party       (300,000)    
Payment of offering costs (117)     (359,666)    
Net cash flows from financing activities 138     251,650,334    
Net change in cash and cash equivalents   (388,599)   440,488    
Cash, beginning of period 440,488      
Cash, end of period   $ 51,889   440,488 $ 440,488  
Non-Cash Investing and Financing Activities:            
Offering costs paid by Sponsor in exchange for issuance of Founder Shares 20,000     20,000    
Remeasurement of Class A ordinary shares subject to possible redemption       12,487,990    
Deferred underwriting fee payable       $ 7,700,000    
Offering costs included in accrued offering costs. $ 5,000